Publications by authors named "Boatemaa Ntiri-Reid"

Article Synopsis
  • Hepatitis Delta Virus (HDV) is a serious type of hepatitis that makes liver problems worse for people who already have Hepatitis B.
  • Many people don't know about HDV, including doctors and those at risk, which makes it hard to diagnose and treat.
  • A special meeting brought together experts and people affected by HDV to discuss ways to raise awareness, improve testing, and ensure better care for patients.
View Article and Find Full Text PDF

In 2014, trained healthcare provider capacity was insufficient to deliver care to an estimated 70 000 persons in Maryland with chronic hepatitis C virus (HCV) infection. The goal of Maryland Community Based Programs to Test and Cure Hepatitis C, a public health implementation project, was to improve HCV treatment access by expanding the workforce. Sharing the Cure (STC) was a package of services deployed 10/1/14-9/30/18 that included enhanced information technology and public health infrastructure, primary care provider training and practice transformation.

View Article and Find Full Text PDF

Introduction: The availability of safe, effective treatments for hepatitis C virus infection has led to a call for the elimination of hepatitis C, but barriers to care persist.

Methods: In July 2015, the Baltimore City Health Department sexual health clinics began on-site hepatitis C virus treatment. Investigators conducted a retrospective evaluation of the first 2.

View Article and Find Full Text PDF

Background: Acute hepatitis B virus (HBV) infections in the United States occur predominantly among persons aged 30-59 years. The Centers for Disease Control and Prevention (CDC) recommends vaccination of adults at increased risk for HBV infection. Completing the hepatitis B (HepB) vaccine dose-series is critical for optimal immune response.

View Article and Find Full Text PDF

Restrictive policies on access to new, curative hepatitis C treatments represent a substantial barrier to treating patients infected with hepatitis C. This case series demonstrates challenges experienced by patients and practitioners in accessing these treatments and highlights several strategies for navigating the treatment preauthorization process.

View Article and Find Full Text PDF